The first principal component of AML gene expression showed a remarkable association with NPM1 and FLT3 mutations in samples with high values of PC1; mutations in TP53 and RUNX1, deletions of 5/5q and 7q, and trisomy 8 coincide with low values of PC1. The gene discussed is TP53; the disease is acute myeloid leukemia.